Your browser doesn't support javascript.
loading
Prevalence of exocrine pancreatic insufficiency in type 2 diabetes mellitus with poor glycemic control.
Terzin, Viktória; Várkonyi, Tamás; Szabolcs, Annamária; Lengyel, Csaba; Takács, Tamás; Zsóri, Gábor; Stájer, Anette; Palkó, András; Wittmann, Tibor; Pálinkás, Attila; Czakó, László.
Afiliación
  • Terzin V; First Department of Internal Medicine, University of Szeged, Szeged, Hungary.
  • Várkonyi T; First Department of Internal Medicine, University of Szeged, Szeged, Hungary.
  • Szabolcs A; First Department of Internal Medicine, University of Szeged, Szeged, Hungary.
  • Lengyel C; First Department of Internal Medicine, University of Szeged, Szeged, Hungary.
  • Takács T; First Department of Internal Medicine, University of Szeged, Szeged, Hungary.
  • Zsóri G; First Department of Internal Medicine, University of Szeged, Szeged, Hungary.
  • Stájer A; Prosthetic Dentistry, University of Szeged, Szeged, Hungary.
  • Palkó A; Radiology Department, University of Szeged, Szeged, Hungary.
  • Wittmann T; First Department of Internal Medicine, University of Szeged, Szeged, Hungary.
  • Pálinkás A; Erzsébet Hospital, Hódmezovásárhely, Hungary.
  • Czakó L; First Department of Internal Medicine, University of Szeged, Szeged, Hungary. Electronic address: czako.laszlo@med.u-szeged.hu.
Pancreatology ; 14(5): 356-60, 2014.
Article en En | MEDLINE | ID: mdl-25278304
ABSTRACT

OBJECTIVES:

To evaluate the relationship between exocrine pancreatic insufficiency and the level of glycemic control in diabetes (DM).

METHODS:

Patients with type 2 DM treated in our clinic were prospectively recruited into the study. Pancreatic diabetes was excluded. Cases with HbA1c ≥7% formed Group A (n = 59), and with HbA1c <7% Group B (n = 42). The fecal level of pancreatic elastase (PE-1) was measured and morphological examinations of the pancreas were performed.

RESULTS:

The PE-1 level was significantly lower in Group A than in Group B (385.9 ± 171.1 µg/g, vs. 454.6 ± 147.3 µg/g, p = 0.038). The PE-1 level was not correlated with HbA1c (r = -0.132, p = 0.187), the duration of DM (r = -0.046, p = 0.65), age (r = 0.010, p = 0.921), BMI (r = 0.203, p = 0.059), or pancreatic steatosis (r = 0.117, p = 0.244). The size of the pancreas did not differ significantly between Groups A and B.

CONCLUSIONS:

An exocrine pancreatic insufficiency demonstrated by fecal PE-1 determination is more frequent in type 2 DM patients with poor glycemic control. The impaired exocrine pancreatic function cannot be explained by an alteration in the size of the pancreas or by pancreatic steatosis.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Insuficiencia Pancreática Exocrina / Hemoglobina Glucada / Diabetes Mellitus Tipo 2 Tipo de estudio: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Pancreatology Asunto de la revista: ENDOCRINOLOGIA / GASTROENTEROLOGIA Año: 2014 Tipo del documento: Article País de afiliación: Hungria

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Insuficiencia Pancreática Exocrina / Hemoglobina Glucada / Diabetes Mellitus Tipo 2 Tipo de estudio: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Pancreatology Asunto de la revista: ENDOCRINOLOGIA / GASTROENTEROLOGIA Año: 2014 Tipo del documento: Article País de afiliación: Hungria